Recent developments in epidemiology, pathogenesis, and treatment of sporotrichosis. • The latest research on leprosy. • Cutaneous infectious diseases in immunocompromised populations. • Studies on the ...

Leprosy has existed for more than 3,000 years and is the one of the oldest diseases known to humanity. Though a cure is available, 200,000 individuals are still diagnosed with the disease each year.

The bacillus Calmette–Guérin (BCG) vaccine, initially developed to provide protection against TB, also protects against leprosy; and the magnitude of this effect varies. Previous meta-analyses ...

While progress has been made in the treatment and management of leprosy, the stigma associated with the disease, along with systemic healthcare challenges, has slowed eradication efforts. Leprosy ...

This prospective cross-sectional study investigated whether IgA, IgM, and IgG anti-lipid antibodies can be used to improve the diagnostic performance for leprosy-affected patients in a high-burden ...

The epidemiology, pathophysiology, differential diagnosis, and treatment of this disease are discussed. Therefore, knowledge and recognition of the most common dermatological lesions in patients with ...

While the abiding theory of CIDP pathogenesis is that cell-mediated and humoral mechanisms act together in an aberrant immune response to cause damage to peripheral nerves, the relative contributions ...

Until recently, pathophysiological models, diagnosis and care of Alzheimer’s disease have been strikingly uncoupled. The dominant pathophysiological theory was the canonical amyloid hypothesis (cAH), ...

School of Biosciences, Faculty of Health and Medical Sciences.

All compounds are either investigational or being studied for (a) new use(s). Efficacy and safety have not been established. There is no guarantee that they will become commercially available for the ...